Thomas McPhaul

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma”.

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-39196-9

N/A

1.4DataRank · unranked

87 citations

Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson +24 more

The impact of a bloodless medicine program on pancreatic resections: A single-institution experience incorporating patients with borderline-resectable and locally advanced pancreatic cancer

Surgical Oncology Insight(2024)10.1016/j.soi.2024.100065

N/A

0DataRank · unranked

0 citations

Julia Purchla, N.C. Cruz, Ananda J. Thomas, Thomas McPhaul, Christopher R. Shubert +7 more